Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.
about
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protectionThe adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsGamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis.Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positiveAlternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effectsCationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system.Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responsesSweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.Determining vaccination frequency in farmed rainbow trout using Vibrio anguillarum O1 specific serum antibody measurementsHigh frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantAdjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensChlamydia muridarum T cell antigens and adjuvants that induce protective immunity in miceThe success and failure of BCG - implications for a novel tuberculosis vaccine.Vaccines for tuberculosis: novel concepts and recent progress.Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesTuberculosis subunit vaccines: from basic science to clinical testing.Cationic liposomes as vaccine adjuvants.Liposomal vaccine delivery systems.Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.Cationic liposomes as vaccine adjuvants.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant.Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines.Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection.Rapid Quantification and Validation of Lipid Concentrations within Liposomes.A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response.Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF).Sensing Lipids with Mincle: Structure and Function.Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.Tailoring Trehalose for Biomedical and Biotechnological Applications.
P2860
Q27305883-D31D51AB-2E78-4943-A8AC-671BB2600124Q33273936-3231F955-0C58-449B-8C42-A801CC852F86Q33416980-FC6EE5FB-B6D1-486B-A722-4BE1BCE2196EQ33459148-DA9AD2D0-27EB-4959-85A1-5EB996F7B8C2Q33558303-C19E1134-1C9A-45AD-A301-427492F5D2E3Q33760570-68B435F9-91FD-43B3-9D22-EA02FEC84F01Q33826107-74F131B6-259E-4719-87B3-75FC982E7F70Q33918586-1B9F44BE-B3CC-4125-9F29-7E52B2571E51Q34034287-922C774D-A302-469C-B5DE-D93A24EC66CEQ34217826-D84F26CB-6462-4EC5-A64C-5B21B09F637CQ34370741-497DB7BF-5AB9-4E00-8F63-C772DB3C4823Q34490356-AAA322D5-FE51-42CC-8460-B44FFCC39EE8Q34681015-5F1C6E58-645D-4993-9630-8E40BD29D99AQ34730713-F174618A-9B23-44B7-8B57-3B52ECE03CA7Q34920323-451BF619-0B4F-420C-9BFC-B19A1F57A3EFQ35593603-0EAF5D6A-32F1-46FC-94CD-78DDD51F6822Q35812875-EFD61C6F-16E8-4596-9BEF-0ECD42F702FBQ35867557-29E1040D-3C32-42EB-AB6A-6B26372AF933Q36191944-DFAD5743-341D-4228-92E6-D3F71C6265EAQ36285657-82E6B3D7-3807-4344-9CDC-3827979FF437Q36909492-0740514A-33D6-4649-8676-8BF4469D8BB2Q36960497-042095B4-D4C8-44DC-BF99-1C985EC2696BQ36968290-9A7283A8-F642-47B9-B836-2C16F8D804B0Q37854063-93CB6EA1-0B47-4398-B419-41534DEB400FQ37856989-FDD9B45B-06EB-456C-BB7A-57A9A0E136E1Q37867105-3D32AAF9-845A-45EC-B4F8-A180B8F0B947Q38028994-C3CFF2F9-E23C-4E7F-AAFC-341937A1D8DFQ38098855-AE944454-E434-4E8F-9553-1D1774144AA1Q38209327-09ADB4D6-14CC-40BB-A504-B6AF9E467B13Q38449050-4E88DFB7-B045-45FF-A1B4-34A162249188Q40089069-0C7C9A51-4B3C-4DA1-8A19-89F15DE716FFQ41201749-EC6C9498-3540-409D-8D7B-935CA1DC985EQ41588441-7D52962D-8DA5-44EA-AD28-66544F7C1F20Q42576378-DCC8FF58-4C3A-43B4-8608-0F1107B33A76Q44461320-BF0A4D38-0CC4-4E7E-AC5E-BF614C8516E2Q45831503-0683F3A4-A0D8-4111-AAF5-438E8D16235AQ45974650-B07D4728-AE6D-49F5-AAFE-30F2F4A4E682Q46243321-330ACF93-DAE0-4464-ACD9-B0ED9B94323AQ46441246-8A535EA9-63F6-4AF3-8544-EF531A6FC3D5Q47095995-1276AA47-B1F5-41DB-90E5-B58FF570B361
P2860
Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combination of the cationic su ...... tuberculosis subunit vaccines.
@ast
Combination of the cationic su ...... tuberculosis subunit vaccines.
@en
type
label
Combination of the cationic su ...... tuberculosis subunit vaccines.
@ast
Combination of the cationic su ...... tuberculosis subunit vaccines.
@en
prefLabel
Combination of the cationic su ...... tuberculosis subunit vaccines.
@ast
Combination of the cationic su ...... tuberculosis subunit vaccines.
@en
P2093
P2860
P1476
Combination of the cationic su ...... tuberculosis subunit vaccines.
@en
P2093
K S Korsholm
L Holten-Andersen
T M Doherty
P2860
P304
P356
10.1128/IAI.72.3.1608-1617.2004
P407
P577
2004-03-01T00:00:00Z